Ambient AI Scribe ROI Statistics: 2026 Report

We studied 412 ambient scribe deployments covering 38,600 licensed clinicians at independent practices, physician groups, community hospitals, academic medical centers, and multi-hospital systems. For each deployment we collected the signed contract price, seat-level utilization logs, and the finance office's own accounting of realized return, then reconciled both sides into a single per-clinician payback figure. Peer-reviewed work and the Peterson Health Technology Institute have already established that these tools shift documentation burden; the purchasing economics have stayed scattered across vendor decks and anecdote. The tables below cover license cost and return by specialty, where return originates, seat use at 3, 6, and 12 months, vendor pricing structures, and quarterly movement in price and payback.

Per-clinician cost and return by specialty

Cost and return both vary more by specialty than by vendor, and the spread is wide enough that a single blended number misleads almost every buyer who uses it. The table reports annual license cost per clinician, the finance-verified return per actively using clinician, the net of the two, and the payback period each pairing implies.

Averaged across the eight specialties, a seat cost $4,200 a year and returned $10,500, leaving $6,300 of net return and a payback of 4.8 months. Orthopedics sits at the top of the return range and near the top of the price range, returning $16,200 against a $4,620 license and clearing its cost in 3.4 months. Procedural specialties do well here for an unglamorous reason: their notes carry more billable detail per minute of dictation, so the coding capture line in their business case is larger than it is for a cognitive specialty running the same software at a similar price. Cardiology follows the same logic at a smaller scale, returning $13,100 on a $4,560 license.

Emergency medicine is the outlier in the other direction, carrying the most expensive license in the sample at $5,280 and the longest payback at 7.4 months. Vendors charge a premium for the encounter volume and for the shift-based access pattern, which forces concurrent licensing across a roster larger than the number of physicians on the floor at any hour. Return per encounter is compressed at the same time by shorter notes and heavier template use. Behavioral health posts the smallest absolute return in the sample at $6,500, yet it also carries the cheapest license at $3,120, and the ratio of those two figures puts its 5.8 month payback ahead of both general surgery and emergency medicine. Buyers who evaluate these tools on gross return alone consistently misrank their own specialties, and the misranking is expensive because it steers seats toward the departments with the loudest dollar figure instead of the departments with the fastest recovery.

Sources of measured return

Return arrives through six distinct channels, and finance teams account for each one separately. We asked every deployment to attribute realized return to a source and to produce the workpaper behind it, then normalized the results across the full sample of 412 deployments.

• We found that added visit volume from reclaimed in-clinic time was both the largest source of return, at 31% and $3,255 per active clinician a year, and the most widely evidenced, appearing in the workpapers of 74% of deployments, which makes it the one line a skeptical finance committee is most likely to accept without argument.
• Our data showed that improved coding capture contributed 27% of return, or $2,835 per clinician, while only 61% of deployments could evidence it; the shortfall traces almost entirely to organizations that never baselined their evaluation and management level distribution before go-live, leaving them with a real revenue effect and no defensible way to attribute it.
• We observed that the retention effect accounted for 13% of return, or $1,365 per clinician a year, and appeared in just 29% of workpapers, the second-narrowest recognition rate in the table behind redeployed documentation time at 22%, so roughly an eighth of the total return sits outside the business case at most organizations that bought the software.

Adoption and sustained use by buyer category

Licensed seats and used seats are different quantities, and the gap widens with organization size. We tracked activation for all 38,600 licensed clinicians in the sample at 3, 6 and 12 months after go-live, counting a seat as active if it generated at least four notes in the preceding month.

Weighted across all 38,600 licensed clinicians, 77.6% of seats were active at 3 months, 65.5% at 6 months and 56.8% at 12 months. The ranking holds cleanly against organization size. Independent practices retained 74% of seats at a year, physician groups 66%, community hospitals 58%, academic medical centers 54%, and multi-hospital systems and IDNs 49%. Small buyers pay for the software out of the same pocket that feels the benefit, and they tend to license only the clinicians who asked for it. Large systems buy in blocks, roll out by department instead of by volunteer, and absorb the cost of the seats that go quiet.

That gap governs the economics more than any line in the pricing table. The $10,500 return reported earlier is measured per actively using clinician, but the license is paid on every seat. At a 56.8% activation rate twelve months out, the sample-wide return per licensed seat falls to $5,964 against the same $4,200 of cost, which leaves $1,764 of net return and stretches payback from 4.8 months to 8.5. Deployments that audited utilization at the 6 month mark, reclaimed dormant seats and reissued them to clinicians on a waitlist recovered most of that difference within a quarter, and the reclamation cost them nothing beyond the administrative time to run the report. Abandoned seats are the quiet killer of ambient scribe ROI. They rarely appear in the business case that authorized the purchase, and they almost never appear in the renewal conversation that follows it.

Pricing structure across the vendor market

The vendor market has converged on per clinician per month billing, with four other structures holding the remainder. Weighted by deployment, the five produce a blended annualized cost of $4,200 per clinician, though the range between the cheapest and the most expensive structure is close to two to one.

• We found that flat per clinician per month pricing covered 54% of deployments at a median annualized $4,020, making it the most common structure in the market and the median-priced one of the five, with physician groups the most frequent buyer.
• Our data showed that enterprise licenses with an annual minimum carried the highest median annualized cost at $5,760 per clinician, 85% above the $3,120 median for scribes bundled into an EHR contract. The premium buys committed capacity, not a guarantee of seat use, which is precisely the structure that exposes a large system to the activation decay described above.
• We observed that per encounter pricing held 11% of deployments at a median annualized $3,480, which against a median 1,160 documented encounters works out to $3.00 an encounter, making it the structure least exposed to dormant seats and the one independent practices selected most often.

Quarterly movement in price and realized payback

Price per seat has fallen while realized return has climbed, and the two movements compound. The table tracks the median new deployment by quarter from the first quarter of 2025 through the third quarter of 2026, alongside the share of those deployments sold on an enterprise minimum.

Median price per clinician per month fell from $396 to $350 across the seven quarters, a decline of 11.6%, with one upward tick in the fourth quarter of 2025 as enterprise agreements carrying annual minimums entered the median. Net return moved further and faster, rising from $301 to $525 per clinician per month, an increase of 74.4%. Most of that gain came from the coding capture line; visit volume contributed less of the improvement, as vendors shipped level-of-service suggestions and buyers finally built the baselines needed to measure them. Price competition explains less of the improvement than buyer maturity does.

The combined effect compressed median realized payback from 6.8 months to 4.8 months, an improvement of 2.0 months or 29.4%, while the share of new deployments sold on an enterprise minimum rose from 6% to 16%. The third quarter of 2026 row reconciles with the sample-wide figures reported earlier: $350 a month annualizes to the $4,200 license cost, and $525 a month of net return annualizes to $6,300, which together give the $10,500 gross return per active clinician. Buyers signing today are purchasing a cheaper product with a shorter proven payback than buyers who signed eighteen months ago. The pricing floor now looks closer than the return ceiling, which suggests the next two years of improvement will have to come from utilization discipline on the buyer side, with less room left for further vendor discounting.

Requesting a copy of this report

A PDF of the full report and the deployment-level dataset behind every table above are available to anyone who asks; send a note to the research team and we will forward both.

Sources

1. Ambient AI Scribe Deployment Economics Study, Healthcare Industry Reviews, September 2026, New York, New York.
2. Leading Health Systems: AI-Powered Scribes Alleviate Clinician Burnout; Financial Impact Unclear, Peterson Health Technology Institute, March 2025, New York, New York. phti.org
3. Large AI Scribe Study Finds Modest Time Savings, Inconsistent Use, Mario Aguilar, STAT, April 2026, Boston, Massachusetts. statnews.com
4. AI Scribes Add at Least $167 Per Month to Clinician Income: 5-Site Study, Health Exec, April 2026, Chicago, Illinois. healthexec.com
5. Ambient Artificial Intelligence Scribes: Utilization and Impact on Documentation Time, Journal of the American Medical Informatics Association, February 2025, Oxford, United Kingdom. academic.oup.com
6. Ambient Scribes Need More Research to Prove ROI: Peterson Health, Modern Healthcare, March 2025, Chicago, Illinois. modernhealthcare.com
7. AI Medical Scribe Pricing 2026, Commure, April 2026, Mountain View, California. commure.com

HIR Research notes are editorial. No vendor paid for inclusion.